Clinical trials
Patient Outcomes clinical trials
Below are recruiting patient outcomes clinical trials, each written for real people, not researchers. We’re tracking 678 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07561424Recruiting
Comparing different dialysis membrane types for kidney patients
This study compares three types of dialysis filters to see which works best at removing waste from your blood and improving your health outcomes. If you receive regular hemodialysis at a clinic, this trial may help doctors understand which filter type is most effective for you.
ParisAges 18 years+ - NCT06298734Recruiting
Exercise and diet study for melanoma patients on immunotherapy
This study tests whether adding high-intensity exercise and a high-fiber diet can improve how well immunotherapy works for people with melanoma. It might help you if you are already on immunotherapy and are not currently very active or eating a lot of fiber.
Boston, MassachusettsAges 18 years+ - NCT07399730Recruiting
Study of ravulizumab outcomes in Polish aHUS patients
This study looks at how well patients with aHUS in Poland are doing after treatment with ravulizumab (Ultomiris). It is for people who have already received this drug through the national program and agree to share their health information.
GdanskAges 18 years+ - NCT06742788Recruiting
Vagus nerve stimulation for IVF patients with anxiety or depression
This trial tests whether a gentle form of nerve stimulation (taVNS) can improve pregnancy rates in women undergoing IVF who also have mild-to-moderate anxiety or depression. It aims to see if this treatment is both helpful and practical for this group.
Xi'an, ShaanxiAges 20–40 - NCT06317558Recruiting
Real-world study of immunotherapy before surgery for lung cancer
This study looks at how well immunotherapy given before surgery works for non-small cell lung cancer. It aims to help doctors understand real-world outcomes for patients who receive this treatment.
Beijing, Beijing MunicipalityAges 18–85 - NCT05569577Recruiting
Extra hCG injections to help pregnancy in IHH
This trial studies whether adding extra hCG shots improves pregnancy outcomes for people diagnosed with IHH, a hormone-related cause of not starting periods. If you’re trying to get pregnant, it may help test whether this added treatment improves your chances.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT03492528Recruiting
Heart care study for people starting cancer treatment
This study follows adults who are referred to a heart (cardio-oncology) specialist before starting cancer treatment. It may help doctors better understand heart outcomes in people with cancer and improve how heart risks are managed early.
MarseilleAges 18 years+ - NCT06400095Recruiting
Breathing Machine Patterns to Predict Recovery in Severe Lung Failure
This study looks at how the breathing machine settings and lung function can help predict recovery in people with severe ARDS. You may be able to join if you are on a ventilator for sudden lung failure and have severe ARDS, as long as you don't have certain other health issues.
Saint Cloud, MinnesotaAges 19–80 - NCT07464808Recruiting
Using a blood test to improve clot prevention in burn patients
This study tests if using a blood test called anti-factor Xa helps doctors give the right amount of blood-thinning medicine to prevent clots in burn patients. It's for adults with moderate-to-large burns who need clot prevention while in the intensive care unit.
Cairo, AbbassiaAges 21 years+ - NCT07628270Recruiting
Heart Surgery Outcomes Study Using CT Scans and Blood Tests
This study follows patients who had heart bypass surgery guided by special CT scans and blood flow measurements. Researchers want to understand how well the surgery works and study a blood protein called Lp(a) that may affect heart health.
Milan, MIAges 18 years+ - NCT06531109Recruiting
Study of patients with alopecia areata treated with ritlecitinib
This study follows people with alopecia areata who are starting treatment with ritlecitinib (a medication). It looks at how well the treatment works in real life and how it affects your symptoms and quality of life.
Birmingham, AlabamaAges 12 years+ - NCT07677267Recruiting
Study of treatment patterns and outcomes for advanced prostate cancer patients
This study looks at real-world data from patients with metastatic castration-resistant prostate cancer (mCRPC) who have already used certain treatments, including a newer drug called lutetium-177 PSMA-617. It aims to understand how these treatments work and what happens to patients over time.
East Hanover, New JerseyAges 18–115 - NCT03617237Recruiting
Radiation patient registry for cancer and non-cancer cases
This study keeps records to understand outcomes for people who had radiation treatment (or were evaluated for it) since 2000. It may help doctors compare results for different conditions and treatment approaches, including cancer and non-cancer problems.
Dallas, TexasAges 18–99 - NCT03876054Recruiting
Tracking outcomes after Abbott neurostimulator implantation
This study follows people long-term after they get an Abbott device implanted to help with chronic pain. It aims to learn how well the therapy works in real-world care over time.
Phoenix, ArizonaAges 18 years+ - NCT04534543Recruiting
Imaging scans to personalize chemotherapy for liver spread of bowel cancer
This trial tests whether special liver imaging can help doctors choose or guide the best chemotherapy for people with liver metastases from gastrointestinal cancer. The study focuses on comparing imaging-based information with outcomes during common chemo treatments like CAPOX or FOLFOX.
AmsterdamAges 18 years+ - NCT04722939Recruiting
Testing brain function outcomes after ICU kidney failure treatment
This trial studies how treating severe kidney injury in the ICU may affect patients’ brain and thinking function over time. It compares measurements of brain activity and function after starting kidney replacement therapy.
Kingston, OntarioAges 18 years+ - NCT04742634RecruitingPhase 1/Phase 2
Preemptive drug DEC-C after transplant to reduce hidden cancer
This trial tests whether giving DEC-C (a decitabine-based treatment) soon after an allogeneic transplant can improve outcomes for MDS patients who still have “measurable residual disease” (hidden leftover disease) detectable by a genetic test. It also compares this approach to standard observation if the hidden disease is not detected or if the higher-risk safety checks are not met.
St Louis, MissouriAges 18–75 - NCT04918524Recruiting
Pregnancy outcomes in women with certain autoimmune conditions
This study looks at the typical pregnancy course and outcomes for women with APS or UCTD, two autoimmune-related conditions. It also checks how these conditions and treatments may affect pregnancy, so doctors can better plan care.
Jinan, ShandongAges 20–45 - NCT04976465RecruitingPhase 1
SLE Treatment During Pregnancy Study
This Phase 1 study looks at a treatment plan for people with systemic lupus (SLE) during pregnancy and tracks health outcomes for mother and baby. It may help doctors learn how to manage SLE safely in pregnancy and what results to expect.
Jinan, ShandongAges 20–45 - NCT05110989Recruiting
Registry study of pain relief after freezing intercostal nerves
This study collects real-world information about how well freezing (cryoablation) of the intercostal nerves helps with pain after a procedure. It may help doctors understand outcomes and improve care for future patients.
Jacksonville, FloridaAges 12 years+ - NCT05321459Recruiting
Testing outcome prediction in comatose patients after cardiac arrest
This study looks at tests that may help predict outcomes in people who remain in a coma 3 to 7 days after surviving a cardiac arrest. It may help doctors better estimate recovery and guide care decisions.
BobignyAges 18 years+ - NCT05572632Recruiting
COPD wellness rehab program for safety-net patients
This trial studies a COPD (chronic lung disease) wellness and rehabilitation program for people who get care through the safety-net health system. It may help improve day-to-day outcomes by supporting safer exercise and better COPD management.
San Francisco, CaliforniaAges 40–90 - NCT05633810RecruitingPhase 3
Testing colchicine plus coated aspirin to prevent heart events
This Phase 3 study tests whether colchicine and a special type of aspirin can lower the risk of future heart attacks, strokes, or other major heart problems in people with type 2 diabetes who have not had a prior heart event. It aims to reduce cardiovascular risk using medicines that may calm inflammation and protect blood vessels.
Bentley, Western AustraliaAges 55–80 - NCT05984745RecruitingPhase 2
CoQ10 for fatty liver linked to metabolic issues
This study tests if CoQ10 (a natural supplement) can improve liver health in people with metabolic dysfunction-associated fatty liver disease (MAFLD). It may help if you have a fatty liver and related metabolic issues like high blood pressure or diabetes.
CairoAges 18–80
Hear when a new Patient Outcomes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient outcomes?
- Yes. Clin2 currently lists 678 recruiting patient outcomes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient outcomes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient outcomes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.